Spelling suggestions: "subject:"fructose 6bisphosphatase"" "subject:"fructose 6biphosphatase""
1 |
Regulation of Fructose 1,6-bisphosphatase II (GlpX) Gene Expression in Escherichia coliCol, Bekir 22 October 2004 (has links)
The glpX gene of Escherichia coli encodes fructose 1,6-bisphosphatase II (FBPase II), an enzyme that would appear to be redundant with FBPase I, encoded by fbp. However, glpX mutants have no apparent phenotype, while fbp mutants are unable to grow on gluconeogenic substrates as sole carbon sources, suggesting that GlpX function is insufficient for growth of fbp mutants under these conditions. To gain insight into the physiological functions of the FBPases, regulation of glpX expression was investigated. It was found that glpX is transcribed as part of a complex glpFKX operon containing promoters upstream of glpF, glpK and glpX (PglpF, PglpK, PglpX, respectively). Transcription start sites of PglpX were found at -24 and -41 relative to the ATG translation initiation site using primer extension analysis. Unlike PglpF, these newly found promoters were not subject to regulation by GlpR or cAMP-CRP. Cra (Catabolite Repressor/Activator) positively regulated expression from PglpK and PglpX by increasing transcription approximately 2 fold. Western analysis using GlpX polyclonal antibodies revealed that GlpX levels were higher in cultures grown on glycerol compared with levels in maltose- or glucose-grown cultures (glycerol>maltose>glucose). Various strains and growth conditions were used to show that GlpX levels are regulated by GlpR, suggesting that PglpF can give rise to expression of glpX. GlpX protein was present in a strain containing a polar insertion in glpK, indicating that PglpX can also give rise to expression of glpX. Strains deficient in FBPase I or CsrA (carbon starvation regulator) did not reveal any difference in GlpX levels with respect to the wild type. All of these data indicate that glpX expression is achieved by its own promoter as well as the operon promoter, PglpF. Finally, the results show that the delta-fbp phenotype is not due to the absence of GlpX. / Ph. D.
|
2 |
Enhanced methylglyoxal formation in cystathionine γ-lyase knockout miceUntereiner, Ashley Anne 24 June 2011
<p>Methylglyoxal (MG) is a reactive glucose metabolite and a known causative factor for hypertension and diabetes. Hydrogen sulfide (H<sub>2</sub>S), on the other hand, is a gasotransmitter with multifaceted physiological functions, including anti-oxidant and vasodilatory properties. The present study demonstrates that MG and H<sub>2</sub>S can interact with and modulate each other's functions. Upon <i>in vitro</i> incubations, we found that MG and H<sub>2</sub>S can directly interact to form three possible MG-H<sub>2</sub>S adducts. Furthermore, the endogenous production level of MG or H<sub>2</sub>S was significantly reduced in a concentration-dependent manner in rat vascular smooth muscle cells (A-10 cells) treated with NaHS, a H<sub>2</sub>S donor, or MG, respectively. Indeed, MG-treated A-10 cells exhibited a concentration-dependent down-regulation of the protein and activity level of cystathionine γ-lyase (CSE), the main H<sub>2</sub>S-generating enzyme in the vasculature. Moreover, H<sub>2</sub>S can induce the inhibition of MG-generated ROS production in a concentration-dependent manner in A-10 cells. In 6-22 week-old CSE knockout male mice (CSE<sup>-/-</sup>), mice with lower levels of vascular H<sub>2</sub>S, we observed a significant elevation in MG levels in both plasma and renal extracts. Renal triosephosphates were also significantly increased in the 6-22 week-old CSE<sup>-/-</sup> mice. To identify the source of the elevated renal MG levels, we found that the activity of fructose-1,6-bisphosphatase (FBPase), the rate-limiting enzyme in gluconeogenesis, was significantly down-regulated, along with lower levels of its product (fructose-6-phosphate) and higher levels of its substrate (fructose-1,6-bisphosphate) in the kidney of 6-22 week-old CSE<sup>-/-</sup> mice. We have also observed lower levels of the gluconeogenic regulator, peroxisome
proliferator-activated receptor-γ coactivator (PGC)-1α, and its down-stream targets, FBPase-1 and -2, phosphoenolpyruvate carboxykinase (PEPCK), and estrogen-related receptor (ERR)α mRNA expression levels in renal extracts from 6-22 week-old CSE<sup>-/-</sup> mice. Likewise, FBPase-1 and -2 mRNA levels were also significantly down-regulated in aorta tissues from 14-16 week-old CSE<sup>-/-</sup> mice. Administration of 30 and 50 µM NaHS induced a significant increase in FBPase-1 and PGC-1α in rat A-10 cells. We have also observed a significant up-regulation of PEPCK and ERRα mRNA expression levels in 50 µM NaHS-treated A-10 cells, further confirming the involvement of H<sub>2</sub>S in regulating the rate of gluconeogenesis and MG formation. Overall, this unique study demonstrates the existence of a negative correlation between MG and H<sub>2</sub>S in the vasculature. Further elucidation of this cross-talk phenomenon between MG and H<sub>2</sub>S could lead to more elaborate and effective therapeutic regimens to combat metabolic syndrome and its related health complications.</p>
|
3 |
Enhanced methylglyoxal formation in cystathionine γ-lyase knockout miceUntereiner, Ashley Anne 24 June 2011 (has links)
<p>Methylglyoxal (MG) is a reactive glucose metabolite and a known causative factor for hypertension and diabetes. Hydrogen sulfide (H<sub>2</sub>S), on the other hand, is a gasotransmitter with multifaceted physiological functions, including anti-oxidant and vasodilatory properties. The present study demonstrates that MG and H<sub>2</sub>S can interact with and modulate each other's functions. Upon <i>in vitro</i> incubations, we found that MG and H<sub>2</sub>S can directly interact to form three possible MG-H<sub>2</sub>S adducts. Furthermore, the endogenous production level of MG or H<sub>2</sub>S was significantly reduced in a concentration-dependent manner in rat vascular smooth muscle cells (A-10 cells) treated with NaHS, a H<sub>2</sub>S donor, or MG, respectively. Indeed, MG-treated A-10 cells exhibited a concentration-dependent down-regulation of the protein and activity level of cystathionine γ-lyase (CSE), the main H<sub>2</sub>S-generating enzyme in the vasculature. Moreover, H<sub>2</sub>S can induce the inhibition of MG-generated ROS production in a concentration-dependent manner in A-10 cells. In 6-22 week-old CSE knockout male mice (CSE<sup>-/-</sup>), mice with lower levels of vascular H<sub>2</sub>S, we observed a significant elevation in MG levels in both plasma and renal extracts. Renal triosephosphates were also significantly increased in the 6-22 week-old CSE<sup>-/-</sup> mice. To identify the source of the elevated renal MG levels, we found that the activity of fructose-1,6-bisphosphatase (FBPase), the rate-limiting enzyme in gluconeogenesis, was significantly down-regulated, along with lower levels of its product (fructose-6-phosphate) and higher levels of its substrate (fructose-1,6-bisphosphate) in the kidney of 6-22 week-old CSE<sup>-/-</sup> mice. We have also observed lower levels of the gluconeogenic regulator, peroxisome
proliferator-activated receptor-γ coactivator (PGC)-1α, and its down-stream targets, FBPase-1 and -2, phosphoenolpyruvate carboxykinase (PEPCK), and estrogen-related receptor (ERR)α mRNA expression levels in renal extracts from 6-22 week-old CSE<sup>-/-</sup> mice. Likewise, FBPase-1 and -2 mRNA levels were also significantly down-regulated in aorta tissues from 14-16 week-old CSE<sup>-/-</sup> mice. Administration of 30 and 50 µM NaHS induced a significant increase in FBPase-1 and PGC-1α in rat A-10 cells. We have also observed a significant up-regulation of PEPCK and ERRα mRNA expression levels in 50 µM NaHS-treated A-10 cells, further confirming the involvement of H<sub>2</sub>S in regulating the rate of gluconeogenesis and MG formation. Overall, this unique study demonstrates the existence of a negative correlation between MG and H<sub>2</sub>S in the vasculature. Further elucidation of this cross-talk phenomenon between MG and H<sub>2</sub>S could lead to more elaborate and effective therapeutic regimens to combat metabolic syndrome and its related health complications.</p>
|
Page generated in 0.0919 seconds